Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Vaccines

Free Subscription Articles published in Virus Res Retrieve available abstracts of 51 articles: HTML format

Single Articles

July 2024
1. ZHANG G, Peng Q, Liu S, Fan B, et al
   The glycosylation sites in RBD of spike protein attenuate the immunogenicity of PEDV AH2012/12.
   Virus Res. 2024;345:199381.
   PubMed     Abstract available
   
   
   June 2024
2. SPEDICATO M, Ronchi GF, Profeta F, Traini S, et al
   Efficacy of an inactivated EHDV-8 vaccine in preventing viraemia and clinical signs in experimentally infected cattle.
   Virus Res. 2024 Jun 17:199416. doi: 10.1016/j.virusres.2024.199416.
   PubMed     Abstract available
   
   
   
3. JALILVAND S, Latifi T, Kachooei A, Mirhoseinian M, et al
   Circulating rotavirus strains in children with acute gastroenteritis in Iran, 1986 to 2023 and their genetic/antigenic divergence compared to approved vaccines strains (Rotarix, RotaTeq, ROTAVAC, ROTASIIL) before mass vaccination: Clues for vaccinatio
   Virus Res. 2024;346:199411.
   PubMed     Abstract available
   
   
   May 2024
4. LIN X, Yang F, Yan S, Wu H, et al
   Preparation and characterization of mouse-derived monoclonal antibodies against the hemagglutinin of the H1N1 influenza virus.
   Virus Res. 2024;345:199402.
   PubMed     Abstract available
   
   
   April 2024
5. WANG Z, Sun W, Li D, Sun Y, et al
   A live attenuated influenza B virus vaccine expressing RBD elicits protective immunity against SARS-CoV-2 in mice.
   Virus Res. 2024;345:199378.
   PubMed     Abstract available
   
   
   
6. AVIZINIENE A, Dalgediene I, Armalyte J, Petraityte-Burneikiene R, et al
   Immunogenicity of Novel vB_EcoS_NBD2 Bacteriophage-Originated Nanotubes as a Carrier for Peptide-Based Vaccines.
   Virus Res. 2024 Apr 11:199370. doi: 10.1016/j.virusres.2024.199370.
   PubMed     Abstract available
   
   
   March 2024
7. CHOWDHURY IR, Viktorova E, Samal SK, Belov GA, et al
   The effect of 5' and 3' non-translated regions on the expression of a transgene from a Newcastle disease virus vector.
   Virus Res. 2024;341:199309.
   PubMed     Abstract available
   
   
   January 2024
8. ZAHEDIPOUR F, Zahedipour F, Zamani P, Jaafari MR, et al
   Harnessing CRISPR Technology for Viral Therapeutics and Vaccines: From Preclinical Studies to Clinical Applications.
   Virus Res. 2024 Jan 9:199314. doi: 10.1016/j.virusres.2024.199314.
   PubMed     Abstract available
   
   
   
9. DESMET C, Coelho-Cruz B, Mehn D, Colpo P, et al
   ASFV epitope mapping by high density peptides microarrays.
   Virus Res. 2024;339:199287.
   PubMed     Abstract available
   
   
   December 2023
10. OTA K, Sakai H, Sasaki D, Mitsumoto-Kaseida F, et al
    Rapid increase in salivary IgA and broad recognition of spike protein following SARS-CoV-2 vaccination.
    Virus Res. 2023 Dec 4:199294. doi: 10.1016/j.virusres.2023.199294.
    PubMed     Abstract available
    
    
    November 2023
11. HASSAN MSH, Ali A, Mahmoud ME, Altakrouni D, et al
    Protection of laying chickens against the Canadian DMV/1639 infectious bronchitis virus infection through priming with heterologous live vaccine and boosting with heterologous or homologous inactivated vaccine.
    Virus Res. 2023 Nov 21:199281. doi: 10.1016/j.virusres.2023.199281.
    PubMed     Abstract available
    
    
    August 2023
12. KO MK, Kim HW, Park SH, Park JH, et al
    The role of zinc sulfate in enhancing cellular and humoral immune responses to foot-and-mouth disease vaccine.
    Virus Res. 2023 Aug 1:199189. doi: 10.1016/j.virusres.2023.199189.
    PubMed     Abstract available
    
    
    July 2023
13. GUO Q, Zhu S, Wang D, Li X, et al
    Genetic characterization and molecular evolution of type 3 vaccine-derived polioviruses from an immunodeficient patient in China.
    Virus Res. 2023;334:199177.
    PubMed     Abstract available
    
    
    
14. PRINS MLM, Prins C, de Vries JJC, Visser LG, et al
    Establishing immunogenicity and safety of needle-free intradermal delivery by nanoporous ceramic skin patch of mRNA SARS-CoV-2 vaccine as a revaccination strategy in healthy volunteers.
    Virus Res. 2023 Jul 18:199175. doi: 10.1016/j.virusres.2023.199175.
    PubMed     Abstract available
    
    
    
15. GOLDEN JW, Fitzpatrick CJ, Suschak JJ, Clements TL, et al
    Induced protection from a CCHFV-M DNA vaccine requires CD8(+) T cells.
    Virus Res. 2023 Jul 15:199173. doi: 10.1016/j.virusres.2023.199173.
    PubMed     Abstract available
    
    
    
16. SUN YY, Liu KS, Yun T, Ni Z, et al
    High expression of the classical swine fever virus (CSFV) envelope protein E2 by a single amino acid mutation and its embedded in the pseudorabies virus (PRV) vector for immunization.
    Virus Res. 2023;331:199111.
    PubMed     Abstract available
    
    
    June 2023
17. TAI W, Zheng J, Zhang X, Shi J, et al
    MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection.
    Virus Res. 2023;334:199156.
    PubMed     Abstract available
    
    
    
18. LIU R, Lv Y, Sun W, Li M, et al
    Investigation of a subunit protein vaccine for HFRS based on a consensus sequence between envelope glycoproteins of HTNV and SEOV.
    Virus Res. 2023;334:199149.
    PubMed     Abstract available
    
    
    
19. SONG Y, Zhao Z, Liu L, Li Y, et al
    Knob domain of Fiber 2 protein provides full protection against fowl adenovirus serotype 4.
    Virus Res. 2023;330:199113.
    PubMed     Abstract available
    
    
    December 2022
20. GALLI C, Pellegrinelli L, Giardina F, Ferrari G, et al
    On the lookout for influenza viruses in Italy during the 2021-2022 season: along came A(H3N2) viruses with a new phylogenetic makeup of their hemagglutinin.
    Virus Res. 2022 Dec 26:199033. doi: 10.1016/j.virusres.2022.199033.
    PubMed     Abstract available
    
    
    
21. KOK BH, Lim HT, Lim CP, Lai NS, et al
    Dengue virus infection - a review of pathogenesis, vaccines, diagnosis and therapy.
    Virus Res. 2022;324:199018.
    PubMed     Abstract available
    
    
    October 2022
22. YAN LN, Li D, Wang ZD, Jiang ZZ, et al
    Neutralizing antibodies and T-cell responses to inactivated SARS-Cov-2 vaccine in COVID-19 convalescents one and a half years after infection.
    Virus Res. 2022 Oct 22:198977. doi: 10.1016/j.virusres.2022.198977.
    PubMed     Abstract available
    
    
    
23. HASSNINE AA, Saber MA, Fouad YM, Sarhan H, et al
    Clinical study on the efficacy of hepatitis B vaccination in hepatitis C virus related chronic liver diseases in Egypt.
    Virus Res. 2022 Oct 6:198953. doi: 10.1016/j.virusres.2022.198953.
    PubMed     Abstract available
    
    
    
24. ZHENZHONG W, Chuanxiang Q, Shengqiang G, Jinming L, et al
    Genetic variation and evolution of attenuated African swine fever virus strain isolated in the field: A review.
    Virus Res. 2022;319:198874.
    PubMed     Abstract available
    
    
    September 2022
25. LUO C, Wang Q, Guo R, Zhang J, et al
    A novel Pseudorabies virus vaccine developed using HDR-CRISPR/Cas9 induces strong humoral and cellular immune response in mice.
    Virus Res. 2022 Sep 26:198937. doi: 10.1016/j.virusres.2022.198937.
    PubMed     Abstract available
    
    
    August 2022
26. HOU LN, Wang FX, Wang YX, Guo H, et al
    Subunit vaccine based on glycoprotein B protects pattern animal guinea pigs from tissue damage caused by infectious bovine rhinotracheitis virus.
    Virus Res. 2022;320:198899.
    PubMed     Abstract available
    
    
    
27. ZHAO Z, Jiang FY, Zhou GQ, Duan HX, et al
    Protective immunity against spring viremia of carp virus by mannose modified chitosan loaded DNA vaccine.
    Virus Res. 2022 Aug 14:198896. doi: 10.1016/j.virusres.2022.198896.
    PubMed     Abstract available
    
    
    July 2022
28. LEGNARDI M, Cecchinato M, Homonnay Z, Dauphin G, et al
    Viral subpopulation variability in different batches of Infectious bronchitis virus (IBV) vaccines based on GI-23 lineage: implications for the field.
    Virus Res. 2022 Jul 21:198877. doi: 10.1016/j.virusres.2022.198877.
    PubMed     Abstract available
    
    
    
29. ABDOLI M, Shafaati M, Ghamsari LK, Abdoli A, et al
    Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2.
    Virus Res. 2022 Jul 9:198857. doi: 10.1016/j.virusres.2022.198857.
    PubMed     Abstract available
    
    
    
30. LI J, Li S, Qiu M, Li X, et al
    Minor and major envelope proteins of PRRSV play synergistic roles in inducing heterologous neutralizing antibodies and conferring cross protection.
    Virus Res. 2022;315:198789.
    PubMed     Abstract available
    
    
    June 2022
31. GONG Y, Sui L, Li Y
    Recombination in Papillomavirus: Controversy and Possibility.
    Virus Res. 2022;314:198756.
    PubMed     Abstract available
    
    
    May 2022
32. JUNG MH, Nikapitiya C, Kim SJ, Han HJ, et al
    Protective immunity induced by ankyrin repeat-containing protein-based DNA vaccine against rock bream iridovirus (RBIV) in rock bream (Oplegnathus fasciatus).
    Virus Res. 2022 May 26:198827. doi: 10.1016/j.virusres.2022.198827.
    PubMed     Abstract available
    
    
    
33. ROWLAND RRR, Doerksen T, Lu A, Sheahan M, et al
    Effect of the host genotype at a Porcine Reproductive and Respiratory Syndrome (PRRS) resistance marker on evolution of the modified-live PRRS vaccine virus in pigs.
    Virus Res. 2022;316:198809.
    PubMed     Abstract available
    
    
    April 2022
34. ALMEIDA F, Santos LA, Trigueiro-Louro JM, RebelodeAndrade H, et al
    Optimization of A(H1N1)pdm09 vaccine seed viruses: the source of PB1 and HA vRNA as a major determinant for antigen yield.
    Virus Res. 2022 Apr 30:198795. doi: 10.1016/j.virusres.2022.198795.
    PubMed     Abstract available
    
    
    
35. WEI N, Wang Q, Lin Z, Xu L, et al
    Systematic profiling of antigen bias in humoral response against SARS-CoV-2.
    Virus Res. 2022;312:198711.
    PubMed     Abstract available
    
    
    March 2022
36. SILVA LMN, Santos MR, Carvalho JA, Carvalho OV, et al
    Molecular analysis of the full-length VP2 gene of Brazilian strains of canine parvovirus 2 shows genetic and structural variability between wild and vaccine strains.
    Virus Res. 2022 Mar 12:198746. doi: 10.1016/j.virusres.2022.198746.
    PubMed     Abstract available
    
    
    
37. XU M, Zhang C, Liu Y, Chen S, et al
    A noval strategy of deletion in PK gene for construction of a vaccine candidate with exellent safety and complete protection efficiency against high virulent Chinese pseudorabies virus variant.
    Virus Res. 2022 Mar 7:198740. doi: 10.1016/j.virusres.2022.198740.
    PubMed     Abstract available
    
    
    
38. AGBLA JM, Esona MD, Jaimes J, Gautam R, et al
    Whole genome analysis of rotavirus strains circulating in Benin before vaccine introduction, 2016-2018.
    Virus Res. 2022 Mar 2:198715. doi: 10.1016/j.virusres.2022.198715.
    PubMed     Abstract available
    
    
    January 2022
39. PERBOLIANACHIS P, Ferla D, Arce R, Ferreiro I, et al
    Phylogenetic analysis of SARS-CoV-2 viruses circulating in the South American region: genetic relations and vaccine strain match.
    Virus Res. 2022 Jan 21:198688. doi: 10.1016/j.virusres.2022.198688.
    PubMed     Abstract available
    
    
    November 2021
40. XIAO T, Leng H, Zhang Q, Chen Q, et al
    Isolation and characterization of a Sabin 3/Sabin 1 recombinant vaccine-derived poliovirus from a child with severe combined immunodeficiency.
    Virus Res. 2021 Nov 15:198633. doi: 10.1016/j.virusres.2021.198633.
    PubMed     Abstract available
    
    
    
41. SUN Y, Li C, Li Z, Shangguan A, et al
    Quercetin as an antiviral agent inhibits the Pseudorabies virus in vitro and in vivo.
    Virus Res. 2021;305:198556.
    PubMed     Abstract available
    
    
    
42. GUPTA D, Parthasarathy H, Sah V, Tandel D, et al
    Inactivation of SARS-CoV-2 by beta-propiolactone causes aggregation of viral particles and loss of antigenic potential.
    Virus Res. 2021;305:198555.
    PubMed     Abstract available
    
    
    September 2021
43. LEI H, Li S, Lu X, Ren Y, et al
    Oral administration of Saccharomyces cerevisiae displaying VP28-VP24 confers protection against white spot syndrome virus in shrimp.
    Virus Res. 2021;302:198467.
    PubMed     Abstract available
    
    
    June 2021
44. LEI L, Qin H, Luo J, Tan Y, et al
    Construction and immunological evaluation of hepatitis B virus core virus-like particles containing multiple antigenic peptides of respiratory syncytial virus.
    Virus Res. 2021;298:198410.
    PubMed     Abstract available
    
    
    May 2021
45. BIDART J, Mignaqui A, Kornuta C, Lupi G, et al
    FMD empty capsids combined with the Immunostant Particle Adjuvant -ISPA or ISA206 induce protective immunity against foot and mouth disease virus.
    Virus Res. 2021;297:198339.
    PubMed     Abstract available
    
    
    April 2021
46. YAN Z, Chen M, Tang D, Wu X, et al
    Better immune efficacy triggered by the inactivated gI/gE-deleted pseudorabies virus with the additional insertion of gC gene in mice and weaned pigs.
    Virus Res. 2021;296:198353.
    PubMed     Abstract available
    
    
    
47. HU Z, Zhao J, Shi L, Hu J, et al
    Identification of the dominant non-neutralizing epitope in the haemagglutinin of H7N9 avian influenza virus.
    Virus Res. 2021;298:198409.
    PubMed     Abstract available
    
    
    
48. KANAI Y, Kobayashi T
    Rotavirus reverse genetics systems: Development and application.
    Virus Res. 2021;295:198296.
    PubMed     Abstract available
    
    
    March 2021
49. FEARON SH, Dennis SJ, Hitzeroth II, Rybicki EP, et al
    Humoral and cell-mediated immune responses to plant-produced African horse sickness virus VP7 quasi-crystals.
    Virus Res. 2021;294:198284.
    PubMed     Abstract available
    
    
    
50. KOTAKI T, Yamanaka A, Konishi E, Kameoka M, et al
    A potent neutralizing mouse monoclonal antibody specific to dengue virus type 1 Mochizuki strain recognized a novel epitope around the N-67 glycan on the envelope protein: A possible explanation of dengue virus evolution regarding the acquisition of N
    Virus Res. 2021;294:198278.
    PubMed     Abstract available
    
    
    January 2021
51. ANWAR MN, Guo S, Xin W, Hameed M, et al
    Adaptation of a live-attenuated genotype I Japanese encephalitis virus to vero cells is associated with mutations in structural protein genes.
    Virus Res. 2021;292:198256.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.